fluconazole has been researched along with prednisolone in 44 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 8 (18.18) | 18.2507 |
2000's | 19 (43.18) | 29.6817 |
2010's | 16 (36.36) | 24.3611 |
2020's | 1 (2.27) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Abraham, MH; Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 2 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Iwamoto, I; Izumi, H; Nawata, Y; Otawa, M; Sueishi, M; Sugiyama, T; Sumida, T; Takabayashi, K; Tanabe, E; Tomioka, H | 1 |
Arakawa, K; Kono, K; Takeda, S; Tatara, I | 1 |
Kliasova, GA | 1 |
Lamey, PJ; Lewis, MA; Nolan, A; Paterson, AJ; Rademaker, M | 1 |
Fujimoto, K; Kubo, K; Sekiguchi, M; Tsushima, K | 1 |
Umezawa, Y | 1 |
Hasegawa, S; Hirano, K; Kadono, K; Oose, H; Saitoh, T; Watanabe, S | 1 |
Fujihara, K; Itoyama, Y; Konno, H; Onodera, J; Sakuma, R; Shiga, Y; Suzuki, Y | 1 |
Discher, T; Friese, G; Füssle, R; Lohmeyer, J; Schmalreck, A | 1 |
Aoki, H; Hayashihara, K; Kudo, S; Nara, M; Noro, R; Saito, T; Suzuki, J; Ueno, T; Watanabe, K | 1 |
Chan, TK; Chee, SP; Cheng, CL; Song, KP | 1 |
Behrens-Baumann, W; König, W; Olbrisch, A; Schreiber, W; Vorwerk, CK | 1 |
Gejyo, F; Hasegawa, G; Iino, N; Ito, S; Narita, I; Nishi, S; Oshima, K; Sasaki, N; Suzuki, E; Takahashi, N; Tanabe, Y; Tsukada, H; Ueno, M | 1 |
Abe, S; Ishibashi, H; Oshima, H; Sato, Y; Takakura, N; Uchida, K; Yamaguchi, H | 1 |
Gander, R; Hoang, MP; Hussey, SM; Southern, P | 1 |
Akhlaghi, F; Gleeson, M; McCaughan, G; McLachlan, AJ; Nelson, A; Zahir, H | 1 |
Beytout, J; Corbain, V; Ferrier, A; Gibold, X; Gourdon, F; Husson, A; Irthum, P; Laurichesse, H; Lesens, O; Vidal, M | 1 |
Bruch-Gerharz, D; Kruse, R; Lewerenz, V; Ruzicka, T | 1 |
Ichikawa, D; Kimura, K; Sato, T; Shima, Y; Tsuchida, H; Yasuda, T | 1 |
Bruch-Gerharz, D; Hengge, U; Homey, B; Marini, A; Meller, S; Ruzicka, T | 1 |
Betbeze, C; Tofflemire, K | 1 |
Ando, T; Ikushima, S; Masunaga, A; Morimoto, K; Oritsu, M; Takemura, T | 1 |
Ainoda, Y; Fujita, T; Hirai, Y; Mori, N; Motoji, T; Shiseki, M; Shoji, T; Teramura, M; Totsuka, K; Yoshinaga, K | 1 |
Li, D; Liu, W; Lv, G; Mei, H; Shen, Y; Wang, C; Wang, L; Zeng, R; Zhan, P | 1 |
Bocanegra, R; Kadosh, D; Kirkpatrick, WR; Najvar, LK; Olivo, M; Patterson, TF; Wiederhold, NP | 1 |
Carrera-Justiz, S; James, MD; Johnson, KL | 1 |
Furukawa, D; Kawahara, T; Ohtani, K; Tsutsui, H; Yakabe, D | 1 |
Kamei, H; Nishioka, H; Takegawa, H | 1 |
Gemke, RJ; Kaspers, GJ; Rensen, N; Rotteveel, J; van Dalen, EC | 1 |
Ichimori, T; Ishikawa, Y; Nagano, S; Oki, Y; Uchida, K; Yamada, T | 1 |
4 review(s) available for fluconazole and prednisolone
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Conversion of chronic necrotizing pulmonary aspergillosis to invasive pulmonary aspergillosis, and successful treatment with fluconazole].
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Antifungal Agents; Arthritis, Rheumatoid; Aspergillosis; Chronic Disease; Disease Progression; Fluconazole; Humans; Immunocompromised Host; Infusions, Intravenous; Lung Diseases, Fungal; Male; Necrosis; Prednisolone | 1997 |
[Three cases of allergic bronchopulmonary mycosis due to Schizophyllum commune].
Topics: Aged, 80 and over; Amphotericin B; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Diagnosis, Differential; Female; Fluconazole; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Middle Aged; Prednisolone; Schizophyllum | 2010 |
Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia.
Topics: Adrenal Insufficiency; Antineoplastic Agents, Hormonal; Child; Cohort Studies; Dexamethasone; Fluconazole; Glucocorticoids; Humans; Hypothalamo-Hypophyseal System; Observational Studies as Topic; Pituitary-Adrenal System; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prednisone; Randomized Controlled Trials as Topic | 2017 |
2 trial(s) available for fluconazole and prednisolone
Article | Year |
---|---|
[Effects of fluconazole on onychomycosis in the patients with collagen diseases].
Topics: Adult; Collagen Diseases; Female; Fluconazole; Humans; Male; Middle Aged; Onychomycosis; Opportunistic Infections; Prednisolone; Prospective Studies | 1995 |
Population pharmacokinetic estimation of tacrolimus apparent clearance in adult liver transplant recipients.
Topics: Administration, Oral; Adolescent; Adult; Aged; Algorithms; Diltiazem; Dose-Response Relationship, Drug; Drug Monitoring; Female; Fluconazole; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Prednisolone; Retrospective Studies; Tacrolimus | 2005 |
38 other study(ies) available for fluconazole and prednisolone
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
ElogPoct: a tool for lipophilicity determination in drug discovery.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Solvents | 2000 |
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
Topics: Blood Proteins; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding | 2002 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
[A case report: cryptococcal meningitis and fluconazole therapy].
Topics: Adolescent; Azathioprine; Female; Fluconazole; Humans; Immunocompromised Host; Lupus Erythematosus, Systemic; Meningitis, Cryptococcal; Prednisolone | 1994 |
[The use of diflucan in myelotoxic agranulocytosis].
Topics: Acute Disease; Adult; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Candidiasis; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Evaluation; Female; Fluconazole; Humans; Leukemia; Prednisolone; Vincristine | 1993 |
Pemphigus vulgaris precipitated by glibenclamide therapy.
Topics: Aged; Azathioprine; Candidiasis, Oral; Diabetes Mellitus, Type 2; Drug Hypersensitivity; Fluconazole; Glyburide; Humans; Hyperglycemia; Male; Metformin; Pemphigus; Prednisolone | 1993 |
Successful treatment of fungus ball in a patient with allergic bronchopulmonary aspergillosis: continuous percutaneous instillation of antifungal agents into the cavity.
Topics: Administration, Inhalation; Administration, Oral; Amphotericin B; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Drug Administration Schedule; Drug Therapy, Combination; Fluconazole; Humans; Infusions, Intravenous; Itraconazole; Male; Middle Aged; Prednisolone; Remission Induction | 1996 |
[Case of allergic bronchopulmonary aspergillosis without complication of asthma attack].
Topics: Anti-Inflammatory Agents; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Aspergillus; Fluconazole; Humans; Lung; Male; Middle Aged; Prednisolone | 1997 |
[Steroid-responsive diffuse cerebral white matter lesions in a case of intractable fungal meningoencephalitis].
Topics: Anti-Inflammatory Agents; Antifungal Agents; Cryptococcosis; Fluconazole; Humans; Male; Meningoencephalitis; Middle Aged; Prednisolone | 1999 |
Development of azole resistance during fluconazole maintenance therapy for AIDS-associated cryptococcal disease.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Chorioretinitis; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Multiple, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Meningitis, Cryptococcal; Pneumonia; Prednisolone; Pyrimidines; Triazoles; Voriconazole | 2001 |
[A case of secondary pulmonary cryptococcosis showing various radiographic changes during its natural course without antifungal treatment].
Topics: Antifungal Agents; Antigens, Fungal; Biomarkers; Cryptococcosis; Diagnosis, Differential; Fluconazole; Humans; Immunocompromised Host; Lung Diseases, Fungal; Male; Middle Aged; Prednisolone; Radiography | 2002 |
PCR-aided diagnosis of fungal chorioretinitis following ingestion of traditional Chinese medication.
Topics: Aged; Amphotericin B; Antifungal Agents; Chorioretinitis; DNA, Fungal; Drug Therapy, Combination; Drugs, Chinese Herbal; Eye Infections, Fungal; Female; Fluconazole; Fluorescein Angiography; Humans; Immunocompromised Host; Medicine, Chinese Traditional; Opportunistic Infections; Polymerase Chain Reaction; Prednisolone; Vitreous Body | 2002 |
Combined topical fluconazole and corticosteroid treatment for experimental Candida albicans keratomycosis.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Conjunctivitis; Cornea; Disease Models, Animal; Drug Therapy, Combination; Eye Infections, Fungal; Female; Fluconazole; Glucocorticoids; Keratitis; Neovascularization, Pathologic; Prednisolone; Rabbits; Time Factors | 2003 |
Adult onset anaphylactoid purpura with severe gastrointestinal involvement.
Topics: Age of Onset; Aged; Antifungal Agents; Antirheumatic Agents; Aspergillosis; Cyclophosphamide; Fatal Outcome; Fluconazole; Gastrointestinal Hemorrhage; Glucans; Humans; IgA Vasculitis; Male; Prednisolone | 2003 |
A novel murine model of oral candidiasis with local symptoms characteristic of oral thrush.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida albicans; Candidiasis, Oral; Chlorpromazine; Disease Models, Animal; Female; Fluconazole; Immunocompromised Host; Mice; Mice, Inbred ICR; Prednisolone; Tetracycline; Virulence | 2003 |
Subcutaneous phaeohyphomycosis caused by Cladophialophora bantiana.
Topics: Adult; Antifungal Agents; Ascomycota; Biopsy; Dermatomycoses; Female; Fluconazole; Glucocorticoids; Humans; Immunocompromised Host; Itraconazole; Lupus Erythematosus, Systemic; Prednisolone; Recurrence | 2005 |
[Cryptococcal meningitis disclosed by visual loss in HIV negative patient with ventriculo-atrial shunting].
Topics: Amphotericin B; Anti-Inflammatory Agents; Antifungal Agents; Blindness; Cerebrospinal Fluid Shunts; Diagnosis, Differential; Drug Therapy, Combination; Eye Infections, Fungal; Fluconazole; Flucytosine; Fludrocortisone; Follow-Up Studies; HIV Seronegativity; Humans; Hydrocephalus; Hydrocortisone; Male; Meningitis, Cryptococcal; Middle Aged; Prednisolone; Sarcoidosis; Time Factors; Treatment Outcome | 2006 |
[Toxic epidermal necrolysis].
Topics: Administration, Oral; Administration, Topical; Adult; Antifungal Agents; Biopsy; Candidiasis, Vulvovaginal; Combined Modality Therapy; Critical Care; Female; Fluconazole; Glucocorticoids; Humans; Prednisolone; Skin; Stevens-Johnson Syndrome; Triamcinolone Acetonide | 2006 |
[A case of cryptococcal meningitis with nephrotic syndrome and renal insufficiency under immunosuppressive therapy].
Topics: Aged; Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Cyclosporine; Drug Administration Schedule; Female; Fluconazole; Humans; Immunosuppressive Agents; Meningitis, Cryptococcal; Nephrotic Syndrome; Prednisolone; Renal Insufficiency | 2007 |
[Rowell syndrome].
Topics: Adult; Amphotericin B; Anti-Inflammatory Agents; Drug Combinations; Erythema Multiforme; Female; Fluconazole; Humans; Lupus Erythematosus, Systemic; Neck; Prednisolone; Syndrome | 2007 |
Three cases of feline ocular coccidioidomycosis: presentation, clinical features, diagnosis, and treatment.
Topics: Animals; Anti-Inflammatory Agents; Antifungal Agents; Cat Diseases; Cats; Coccidioidomycosis; Eye Diseases; Female; Fluconazole; Male; Prednisolone; Prednisone | 2010 |
Disseminated cryptococcosis in a non-Hodgkin's lymphoma patient with late-onset neutropenia following rituximab-CHOP chemotherapy: a case report and literature review.
Topics: Aged; Amphotericin B; Antibodies, Monoclonal, Murine-Derived; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Cryptococcosis; Cryptococcus neoformans; Cyclophosphamide; Doxorubicin; Female; Fluconazole; Flucytosine; Humans; Immunologic Factors; Lymphoma, Non-Hodgkin; Neutropenia; Prednisolone; Rituximab; Treatment Outcome; Vincristine | 2011 |
Combination of Estrogen and Immunosuppressive Agents to Establish a Mouse Model of Candidiasis with Concurrent Oral and Vaginal Mucosal Infection.
Topics: Animals; Antifungal Agents; Candida; Candidiasis, Oral; Candidiasis, Vulvovaginal; Colony Count, Microbial; Disease Models, Animal; Estrogens; Female; Fluconazole; Immunosuppressive Agents; Interleukin-17; Interleukin-23; Mice, Inbred ICR; Prednisolone | 2016 |
Effect of Antifungal Treatment in a Diet-Based Murine Model of Disseminated Candidiasis Acquired via the Gastrointestinal Tract.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Caspofungin; Colony Count, Microbial; Cyclophosphamide; Diet; Disease Models, Animal; Echinocandins; Fluconazole; Gastrointestinal Tract; Humans; Immunocompromised Host; Immunosuppressive Agents; Lipopeptides; Male; Mice; Mice, Inbred BALB C; Prednisolone; Survival Analysis | 2016 |
What Is Your Neurologic Diagnosis?
Topics: Amphotericin B; Animals; Anti-Inflammatory Agents; Antifungal Agents; Blindness; Cat Diseases; Cats; Fluconazole; Male; Meningitis, Cryptococcal; Prednisolone | 2017 |
Candida oesophagitis incidentally detected by fluorine-18 fluorodeoxyglucose positron emission tomography in a patient with sarcoidosis.
Topics: Candida albicans; Candidiasis; Esophagitis; Female; Fluconazole; Fluorodeoxyglucose F18; Humans; Incidental Findings; Middle Aged; Positron-Emission Tomography; Prednisolone; Radiographic Image Enhancement; Sarcoidosis; Treatment Outcome | 2017 |
Disseminated cryptococcosis in a patient taking tocilizumab for Castleman's disease.
Topics: Amphotericin B; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Antifungal Agents; Castleman Disease; Cryptococcosis; Cryptococcus neoformans; Cyclosporine; Fluconazole; Humans; Immunosuppressive Agents; Male; Middle Aged; Prednisolone; Risk Factors | 2018 |
Ulcerative colitis successfully treated with vedolizumab in the presence of comorbid opportunistic infections: a case report.
Topics: Colitis, Ulcerative; Cytomegalovirus Infections; Fluconazole; Humans; Inflammatory Bowel Diseases; Male; Middle Aged; Opportunistic Infections; Prednisolone | 2023 |